Neurosurgery for Psychiatric Disorders: Reassessing the Risk of Cognitive Side Effects


April 13, 2026

image of synapseChallenging a Long-Standing Barrier in Psychiatry

For decades, one of the most persistent barriers to the use of neurosurgical interventions in psychiatry has been the concern over neuropsychological side effects (NPSE).

These concerns are deeply rooted in the history of early psychosurgical procedures, which were associated with significant morbidity and have shaped both public perception and clinical hesitation.

A newly published systematic review and meta-analysis, conducted by an international consortium of experts—including our team at UTHealth Houston—provides a critical reassessment of this issue.

Why This Matters Now

Psychiatric disorders are among the leading causes of global disability, and a substantial proportion of patients remain treatment-resistant despite:

  • Pharmacotherapy
  • Psychotherapy
  • Neuromodulation (TMS, ECT)

In fact:

  • 20–60% of patients with major depression
  • 20–40% with OCD
  • 20–60% with schizophrenia

may not respond adequately to conventional treatments.

For these patients, neurosurgery for psychiatric disorders (NPD) may represent a last-resort—but potentially life-changing—intervention.

What Did This Study Do?

This study analyzed data from:

  • 48 studies
  • 2,678 patients

across four major surgical categories:

  • Neurosurgery for psychiatric disorders (NPD)
  • Epilepsy surgery
  • Neurovascular surgery
  • Neuro-oncological surgery

The goal was straightforward but important:

To determine whether neuropsychological risks in psychiatric neurosurgery are truly higher than in other accepted neurosurgical procedures

Key Findings

Neuropsychological Risks Are Comparable

The study found that:

  • Transient NPSE: ~0.9% to 11.5% in psychiatric neurosurgery
  • Permanent NPSE: ~0.9% to 2.0%

These rates were comparable to those observed in epilepsy, vascular, and oncological neurosurgery.

This directly challenges the assumption that psychiatric neurosurgery carries disproportionate cognitive risk.

In Some Domains, Outcomes Are Better

Compared to epilepsy surgery, psychiatric neurosurgery showed:

  • Better outcomes in:
    • Memory
    • Language
    • Social cognition

However, there were trade-offs:

  • Slightly worse outcomes in:
    • Executive function
    • Perceptual-motor function

Compared to Other Neurosurgical Fields

  • Versus vascular surgery:
    • Better executive function
    • Worse complex attention
  • Versus oncological surgery:
    • Fewer permanent deficits in several domains
    • Slightly lower language performance

The Bigger Message: A Misperception

One of the most important conclusions of this work is:

Concerns about neuropsychological side effects in modern psychiatric neurosurgery are likely exaggerated

These concerns are largely based on:

  • Historical procedures (e.g., prefrontal lobotomy)
  • Outdated techniques
  • Cultural and media narratives

Modern procedures, in contrast, are:

  • Highly targeted
  • Image-guided (MRI-based)
  • Performed with stereotactic precision

Clinical Implications

1️. Reconsidering Neurosurgery in TRD and OCD

For carefully selected patients, neurosurgical interventions should be viewed as:

A valid and evidence-based option, not an extreme last resort

2️. Reducing Stigma

This study provides strong evidence to:

  • Educate clinicians
  • Inform patients
  • Shift public perception

3️. Expanding Access to Care

Underutilization of these treatments is not only a scientific issue—it is a systems and perception problem.

Addressing misconceptions could significantly expand access for patients with severe, refractory illness.

4️. Aligning Psychiatry with Other Specialties

Other fields routinely accept similar or higher risks:

  • Epilepsy surgery
  • Brain tumor resection
  • Vascular neurosurgery

Yet psychiatric neurosurgery remains more restricted.

This discrepancy deserves reconsideration.

UTHealth Houston Perspective

At the Center for Interventional Psychiatry at UTHealth Houston, we are committed to:

  • Advancing evidence-based interventional treatments
  • Reducing stigma around neuromodulation and neurosurgery
  • Developing comprehensive care pathways for treatment-resistant disorders

This work reflects a global effort to move the field forward by bringing together neurosurgeons, psychiatrists, neurologists, and neuroscientists.

Final Thoughts

Neurosurgery for psychiatric disorders remains one of the most underutilized tools in modern medicine—not because of lack of evidence, but because of persistent misconceptions.

This study provides a clear message:

Modern psychiatric neurosurgery is no more dangerous than other accepted brain surgeries

For patients with severe, treatment-resistant conditions, this represents an important shift:

  • From fear → to evidence
  • From stigma → to science
  • From last resort → to considered option

Reference

Vilela-Filho O, Bannach MA, Lino-Filho AM, et al. Comparison of neuropsychological side effects between contemporary radiofrequency ablative neurosurgery for psychiatric disorders and conventional neurosurgical procedures: systematic review and meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry. 2026.

Contact

Request for Second Opinion Form – https://Go.uth.edu/CIPIntake
Phone – (713) 486-2621
Fax – (713) 500-2728
E-mail – [email protected]
Website – https://go.uth.edu/CIP

Disclaimer

This article was created with the assistance of artificial intelligence (AI) to help organize and refine the presentation of scientific information. All medical and scientific content has been reviewed and approved by Joao L. de Quevedo, MD, PhD, Executive Director of the Center for Interventional Psychiatry at the John S. Dunn Behavioral Sciences Center at UTHealth Houston. The content is intended for educational and informational purposes only and does not substitute for professional medical advice.